Aflac Incorporated (NYSE:AFL) is included among the Top 15 Growth Stocks for Long-Term Investors.
An American insurance company, Aflac Incorporated (NYSE:AFL), mainly focuses on supplemental health and life insurance. The Japanese market plays a vital role in Aflac’s overall performance, contributing a substantial share of its earnings. In the second quarter of 2025, Aflac Japan reported net earned premiums of ¥254.6 billion. The company recorded a 23.2% year-over-year increase in sales, supported by strong premium persistency. Much of this growth was driven by the success of its new cancer insurance product, Miraito.
Aflac Incorporated (NYSE:AFL) continues to prioritize innovation, product development, and the expansion of its distribution network through strategic partnerships. The company’s current focus lies in strengthening its distribution channels and enhancing its product portfolio to align with changing customer needs. Success for the company depends on its ability to develop competitive products, deepen market penetration, and effectively manage regulatory requirements across both Japan and the United States.
In addition to its global presence, Aflac Incorporated (NYSE:AFL) is widely known because of its status as one of the best dividend aristocrat stocks. The company has been rewarding shareholders with growing dividends for the past 42 years and currently pays a quarterly dividend of $0.58 per share. As of October 12, the stock has a dividend yield of 2.09%.
While we acknowledge the potential of AFL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Most Promising Dividend Stocks According to Wall Street Analysts and 14 Best Food Dividend Stocks To Buy According to Analysts.
Disclosure: None.